GWPH News and Press, GW Pharmaceuticals Plc From 09/03/20

If you want to invest in cannabis companies that are safe, long-term bets, you might be hard-pressed to find a few standouts. If one thing's for certain, though, it's that investors should at least consider picking stocks that aren't dependent on recreational marijuana, where future growth is st...

Shares of GW Pharmaceuticals (NASDAQ: GWPH) have been sliding since the company reported quarterly results that were arguably positive. Even though GW Pharmaceuticals reported second-quarter product sales that grew 70% year over year, its stock price has tumbled about 20% since announci...

GW Pharmaceuticals ( GWPH ) saw its stock price fall sharply on the publication of its recent results. This may have been due more to stock manipulation by a few substantial stock owners rather than fundamentals. Analysts remained positive on the stock. As my recent article detailed, the c...

Over the past 16 months, investing in the cannabis space has been challenging , to say the least. All next-big-thing investments eventually run into growing pains, and April 2019 marked the beginning of these hurdles for the North American pot industry. To our north, regulatory-based supply co...

Psychedelic drug treatments are quickly going mainstream, with new coverage surfacing from 60 Minutes . In fact, they speak about how psilocybin for example is helping participants do things like quitting smoking and worrying far less. “Early results are impressive, as are the experie...

During good times, pharma stocks are often great buys thanks to their steady cash flow, high-profit margins, dedication to research and development, and market exclusivity from drug patents. In a global pandemic, however, pharma companies become even better buys, because of the essential nature ...

You Might Not Be Familiar With These Marijuana Stocks To Watch The future of the cannabis industry depends on several factors. The most important factor for pot stocks to see success is legislation. In North America, we have seen the most progressive laws for marijuana stocks when compared...

Editors' Note: This is the transcript version of the podcast we published last Wednesday with Rahul Bhushan. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the podcast, embedded below, if you need any clarification. We...

The psychedelics boom is alive and well thanks in part to a landmark decision on psilocybin mushrooms. Just days ago, the Canadian government allowed four terminally ill patients with cancer to receive psilocybin therapy to help ease end-of-life distress. This is the first time in 46 years th...

Despite the growing popularity of cannabis, there's limited information about what the substance can and cannot do. And with marijuana classified as a Schedule 1 substance in the U.S., it's nearly impossible for researchers to conduct studies on it. In Canada, however, pot's legal for both medic...